Multiple Myeloma RF

Multiple Myeloma Research Foundation - Accelerating the development of next generation #myeloma treatments to extend patients' lives, and lead to a cure.

[Multiple Myeloma RF @theMMRF]

Over the last 15 years, the CoMMpass study has changed how we understand and treat multiple myeloma. And with the study data now powering MMRF Virtual Lab, the largest open-source myeloma data platform, its impact will continue for years to come.

https://t.co/QSNhvBl8bz

[Multiple Myeloma RF @theMMRF]

Stay informed with @cure_today magazine's quarterly print publication featuring expert insights, treatment updates, patient stories, and more. Delivered to your mailbox at no cost.

Subscribe today: https://t.co/JXLIwJwPWo

[Multiple Myeloma RF @theMMRF]

At 35, Michelle Carlberg was diagnosed with multiple myeloma and told she might never run again. A decade later, she's run Boston, Chicago, New York, and Berlin Marathons with MMRF Team for Cures. Want to run for a cure? Join us: https://t.co/hi1YpkuyQW

[Multiple Myeloma RF @theMMRF]

@Ange_Loiseau @WMMajors We're grateful for your support!

[Multiple Myeloma RF @theMMRF]

We recently hosted the MMRF Immunity Workshop, which focused on how AI and data can help improve outcomes for myeloma patients. Read 9 takeaways from a day of conversations that could shape what comes next for myeloma patients: https://t.co/oXlI6dIdoU

[Multiple Myeloma RF @theMMRF]

The MMRF CoMMpass Study turns 15 this month. Since 2011, the Study has transformed how the field understands multiple myeloma and continues to power research and care today.

Read the full story: https://t.co/SdcDa5EvEO

[Multiple Myeloma RF @theMMRF]

The latest Multiple Myeloma Hub Steering Committee meeting featured an expert discussion, led by Lisa Leypoldt, on managing the ocular toxicities associated with belantamab mafodotin.

[Multiple Myeloma Hub @MM_Hub]

How can ocular toxicities associated with belantamab mafodotin be effectively monitored and managed in clinical practice?

Learn more: https://t.co/bF5Q4uXYDb

#MultipleMyeloma #myeloma #mmsm #MedEd @MilesPrince4 @DrRakeshPopat @heinzludwig4

[Multiple Myeloma RF @theMMRF]

Mike still remembers the shock of the moment when his oncologist told him he was 95 percent sure he had myeloma. He was blindsided. Today, he’s in remission and pretty much doing everything he did before his diagnosis.

Support patients like Mike: https://t.co/TAOSFoE1S8

[Multiple Myeloma RF @theMMRF]

Cancer research efforts are often independent and disconnected. MMRF Virtual Lab® changes that.

Learn More: https://t.co/yzI7ZCOFsZ

[Multiple Myeloma RF @theMMRF]

NEWS: The FDA has approved a new wearable, subcutaneous delivery option for Sarclisa® (isatuximab-irfc) for certain multiple myeloma patients. This could mean less time in the clinic and a more convenient treatment experience. Learn more: https://t.co/WNfsQz4BRy

[Multiple Myeloma RF @theMMRF]

One week left. MMRF Research Fellowship Scholars applications must be submitted by July 15 at 11:59 PM ET.

You could receive $75K to pursue myeloma research. More info: https://t.co/HRBEg2Eh9y

[Multiple Myeloma RF @theMMRF]

When Eric Dillon started feeling pain in his shoulder, he chalked it up to a strained rotator cuff. The aches became a part of daily life, but then he felt a burst of tremendous pain while doing yard work. Tests confirmed Dillon had multiple myeloma. https://t.co/jSQegzfHds

[Multiple Myeloma RF @theMMRF]

If you were recently diagnosed with multiple myeloma, one of the most important steps you can take is finding a myeloma specialist. The Find a Specialist tool on our website is a great place to start: https://t.co/zU4YXprE5X

[Multiple Myeloma RF @theMMRF]

Create your own fundraising event to support the MMRF and help advance research, new treatments, and ultimately, a cure for myeloma.

Get started: https://t.co/AUFxFOXibc

[Multiple Myeloma RF @theMMRF]

Data will drive the next breakthroughs—and cures—in multiple myeloma. But we have a data siloing problem. That’s why we’re excited to launch MMRF Virtual Lab, the largest open-access clinical and genomic dataset on multiple myeloma.

Learn more: https://t.co/yzI7ZCOFsZ

[Multiple Myeloma RF @theMMRF]

The Multiple Myeloma Hub provides balanced, credible, and up-to-date medical education. This resource explores bispecific antibody treatment for #MultipleMyeloma, including considerations for CRS risk mitigation, recognition, and management.

https://t.co/PsQVTBU496
#myeloma

[Multiple Myeloma Hub @MM_Hub]

New publication 📝 We highlight key strategies for CRS risk mitigation and prophylaxis, recognition and monitoring, and management during BsAb treatment for RRMM in community practice.

Learn more: https://t.co/RtFiAW043X

#myeloma #mmsm #MedNews #MedEd

[Multiple Myeloma RF @theMMRF]

MMRF Chief Medical Officer Hearn Jay Cho, MD, PhD spoke with Patient Power about iberdomide, a medication that's part of a new class of agents called CELMoDs.

Learn more: https://t.co/22VamSy8dE

[Multiple Myeloma RF @theMMRF]

One week left. MMRF Scholars applications must be submitted by June 30 at 11:59 PM ET.

You could receive $400K over 4 years to pursue myeloma research. More info: https://t.co/3sNhmdGMx4

[Multiple Myeloma RF @theMMRF]

After being diagnosed with multiple myeloma in 2023, Spencer Swann didn't think running a marathon was possible. Then he ran the @ChiMarathon with the MMRF. Spencer proves life doesn't stop at diagnosis. Want to run for a cure? https://t.co/Uy2KmnT96k

[Multiple Myeloma RF @theMMRF]

This Father's Day Jonathan Gluck, a 20-year myeloma survivor and dad of two, shares why he gives to the MMRF. Honor someone you love with a gift that gives families more time: https://t.co/56hDZjPKFn